CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $751,000, lower than 95% of all stocks globally
- PositionGross margin is 7.7%, lower than 95% of its Medical Instruments & Supplies peers (median 49.2%)
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.98BUSDvs all stocks (USD)
Revenue (TTM)
751.00KUSDvs all stocks (USD)
Profit Margin
-54.00%vs Medical Instruments & Supplies peers
Beta
1.65xvs all stocks
52-Week Change
91.58%vs all stocks
Market Capitalization
1.98BUSDvs all stocks (USD)
Enterprise Value
1.92BUSDvs all stocks (USD)
Forward P/E
-26.31xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
29.51xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.56Kxvs Medical Instruments & Supplies peers
Enterprise to EBITDA
-25.18xvs Medical Instruments & Supplies peers
Gross Margin
7.73%vs Medical Instruments & Supplies peers
Profit Margin
-54.00%vs Medical Instruments & Supplies peers
Operating Margin
-4775.56%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
-45.03%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
-80.72%vs Medical Instruments & Supplies peers
Revenue (TTM)
751.00KUSDvs all stocks (USD)
Revenue per Share (TTM)
0.0110USDUpdated Jul 19, 2026Quarterly Revenue Growth
51.89%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
-158.00KUSDvs all stocks (USD)
EBITDA (TTM)
-76.40MUSDvs all stocks (USD)
Net Income (TTM)
-74.57MUSDvs all stocks (USD)
Operating Cash Flow (TTM)
-55.20MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-29.08MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Revenue
350.00KUSDFY2025 · Dec 31, 2025Cost of Goods Sold
539.00KUSDFY2025 · Dec 31, 2025Gross Profit
-189.00KUSDFY2025 · Dec 31, 2025Operating Income
-76.94MUSDvs all stocks (USD)
Pre-tax Income
-72.78MUSDFY2025 · Dec 31, 2025Net Income
-72.78MUSDFY2025 · Dec 31, 2025EBIT
-76.94MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-75.87MUSDFY2025 · Dec 31, 2025Research & Development
44.72MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
32.03MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
4.21MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-72.78MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-49.76MUSDFY2025 · Dec 31, 2025Free Cash Flow
-50.08MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
80.73MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-72.78MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.07MUSDFY2025 · Dec 31, 2025Stock-based Compensation
21.46MUSDFY2025 · Dec 31, 2025Other Non-cash Items
1.15MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-274.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.13MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.52MUSDFY2025 · Dec 31, 2025Capital Expenditures
-315.00KUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-20.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-315.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
0.00USDFY2025 · Dec 31, 2025Shares Outstanding
68.23MSharesUpdated Jul 19, 2026Float Shares
18.48MSharesUpdated Jul 19, 2026Shares Short
2.86MSharesUpdated Jul 19, 2026Short Ratio
7.50daysvs all stocks
Short % of Shares Outstanding
14.86%vs all stocks
% Held by Insiders
73.21%vs all stocks
% Held by Institutions
11.59%vs all stocks
Total Cash (MRQ)
68.32MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9870USDUpdated Jul 19, 2026Total Debt (MRQ)
7.16MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1079xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
7.26xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
0.9720USDUpdated Jul 19, 2026Total Assets
94.54MUSDvs all stocks (USD)
Total Current Assets
83.42MUSDFY2025 · Dec 31, 2025Total Liabilities
13.88MUSDFY2025 · Dec 31, 2025Total Non-current Assets
11.12MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
5.96MUSDFY2025 · Dec 31, 2025Total Current Liabilities
7.92MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
80.73MUSDFY2025 · Dec 31, 2025Accounts Receivable
274.00KUSDFY2025 · Dec 31, 2025Inventory
136.00KUSDFY2025 · Dec 31, 2025Accounts Payable
2.78MUSDFY2025 · Dec 31, 2025Short-term Debt
1.57MUSDFY2025 · Dec 31, 2025Long-term Debt
5.96MUSDFY2025 · Dec 31, 2025Common Stock (Book)
68.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-463.28MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
80.66MUSDvs all stocks (USD)
52-Week Low
12.56USDUpdated Jul 19, 202652-Week High
31.00USDUpdated Jul 19, 202652-Week Change
91.58%vs all stocks
Beta
1.65xvs all stocks
50-Day MA
25.60USDUpdated Jul 19, 2026200-Day MA
19.67USDUpdated Jul 19, 2026Avg 10-Day Volume
261.45KSharesUpdated Jul 19, 2026Avg 30-Day Volume
344.11KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
-1.10USDUpdated Jul 19, 2026Other Income / Expense
-52.00KUSDFY2025 · Dec 31, 20254 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 7.7%, lower than 95% of its Medical Instruments & Supplies peers (median 49.2%)Significant
Gross margin: 0.08Industry median: 0.49Industry P5: 0.16Peers compared: 65.00
Operating margin is -4775.6%, lower than 95% of its Medical Instruments & Supplies peers (median 11.9%)Significant
Operating margin: -47.76Industry median: 0.12Industry P5: -0.16Peers compared: 65.00
Profit margin is -54%, lower than 95% of its Medical Instruments & Supplies peers (median 8.2%)Significant
Profit margin: -0.54Industry median: 0.08Industry P5: -0.45Peers compared: 65.00
Return on equity is -80.7%, lower than 95% of its Medical Instruments & Supplies peers (median 5.6%)Significant
Return on equity: -0.81Industry median: 0.06Industry P5: -0.46Peers compared: 65.00
Return on assets is -45%, lower than 95% of its Medical Instruments & Supplies peers (median 4%)Significant
Return on assets: -0.45Industry median: 0.04Industry P5: -0.17Peers compared: 65.00
Price-to-book is 29.51×, higher than 95% of its Medical Instruments & Supplies peers (median 2.65×)Significant
Price-to-book: 29.51Industry median: 2.65Industry P95: 9.29Peers compared: 65.00
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.59
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $751,000, lower than 95% of all stocks globallySignificant
Revenue (USD): 751,000Global P5: 30,274,777.221
Market cap is $1.98B, above the global median of $1.15BNotable
Market cap (USD): 1,984,934,540Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Guangdong Skychem Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Anhui Jiangnan Chemical Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shenzhen Gongjin Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
AddLife AB
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Swcc Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
GCS Holdings, Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Xizi Clean Energy Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huaxia Eye Hospital Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
SCG Packaging Public Company Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dai-Dan Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
LB Pharmaceuticals Inc.
4 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Vicor Corporation
4 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Jiangxi JDL Environmental Protection Co. Ltd.
3 interpretationsCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedLow-Leverage Liquidity Configuration